© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
Contagion, May 2022 (Vol. 07, No. 2)
Community-Acquired Candida Glabrata Empyema: An Atypical Diagnosis Not to Miss
May 31, 2022
Article
Case Study
Although this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.
COVID-19 Expectations on the Rollout of the Booster Shots
May 31, 2022
Article
Peer Exchange
Medical professionals discuss how they affect immunity as well as the necessity of these additional vaccinations.
COVID-19 Impact on Antimicrobial Stewardship: Consequences and Silver Linings
May 31, 2022
Article
Stewardship & Prevention
This crisis has united multidisciplinary groups and laid the foundation to better equip the health care workforce for future pandemics.
Lessons in Resilience: What HIV Teaches Us About COVID-19
May 31, 2022
Article
HIV / AIDS
Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.
Opposing Forces During COVID-19: Perspective From the ICU
May 31, 2022
Article
Acute Infections
Conflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.
Taking It As It Comes: Creating Evidence-Based Guidelines During a Rapidly Changing Pandemic
May 31, 2022
Article
News and Breakthroughs
With few exceptions, COVID-19 therapies have not been studied comparatively, so choosing therapies to preferentially recommend is difficult and is done, instead, by strength of evidence and quality of data.
Pharmacotherapy Options for COVID-19: Does Fluvoxamine Have a Place in Therapy?
May 31, 2022
Article
In the Literature
The need for safe and effective treatment against the various strains of COVID-19 increase, and investigators continue to assess various pharmacologic options.
Regdanvimab—A New Attack of the (Mono)Clones
May 19, 2022
Article
In the Literature
A review of the neutralizing antibody that was studied in a phase 2/3 trial in outpatients with mild to moderate infections of COVID-19.
Considering Mandatory COVID-19 Vaccination Policies for Students
May 18, 2022
Article
Emerging & Re-Emerging Infections
Public health and school officials need to consider strategies now.
An Issue About COVID-19
May 17, 2022
Article
Editor-in-Chief Letter
As we recently surpassed the 2-year mark of the pandemic, the May issue reflects on lessons learned thus far.
The Underlying Threat of Multidrug-Resistant Pathogens in the COVID-19 Era
May 16, 2022
Article
Multidrug-Resistant Infections
Over half of patients admitted with positive SARS-CoV-2 testing received antibiotics, but evidence of bacterial infection is uncovered in far fewer cases. We may already be seeing the effects of antibiotic overprescribing.